Cardiotrophin-1 is associated with increased risk of arterial stiffness

Biomarkers in Medicine

Volumn 9, Issue 2, 2015, Pages 123-130

  Hung, Hao Chang ^a,b   Lu, Feng Hwa ^a,c   Ou, Horng Yih ^a,c   Wu, Hung Tsung ^b   Wu, Jin Shang ^a,c   Yang, Yi Ching ^a,c   Chang, Chih Jen ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Arterial stiffness; Brachial ankle pulse wave velocity; Cardiotrophin 1

Indexed keywords

C REACTIVE PROTEIN; CARDIOTROPHIN 1; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; CYTOKINE; HIGH DENSITY LIPOPROTEIN;

ADULT; AGE; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; AUTOANALYZER; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; GENDER; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PREHYPERTENSION; PULSE WAVE; RISK ASSESSMENT; SMOKING; AGED; BLOOD; BODY MASS; CARDIOVASCULAR DISEASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; STATISTICAL MODEL;

MUS;

ADULT; AGED; ANKLE BRACHIAL INDEX; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPROTEINS, HDL; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULSE WAVE ANALYSIS; RISK FACTORS; TRIGLYCERIDES; VASCULAR STIFFNESS;

EID: 84923457688     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/BMM.14.87     Document Type: Article

References (33)

1. Pennica D, Shaw KJ, Swanson TA et al. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 270(18), 10915-10922 (1995).
2. Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown JH, Chien KR. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J. Biol. Chem. 272(9), 5783-5791 (1997).
3. López B, González A, Lasarte JJ et al. Is plasma cardiotrophin-1 a marker of hypertensive heart disease? J. Hypertens. 23(3), 625-632 (2005).
4. López B, Castellano JM, González A, Barba J, Díez J. Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension. Hypertension 50(5), 977-983 (2007).
5. López B, González A, Querejeta R, Barba J, Díez J. Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications. J. Hypertens. 27(2), 418-424 (2009).
6. Talwar S, Squire IB, Downie PF, O'Brien RJ, Davies JE, Ng LL. Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clin. Sci. 99(1), 83-88 (2000).
7. González A, López B, Ravassa S et al. Cardiotrophin-1 in hypertensive heart disease. Endocrine 42(2), 9-17 (2012).
8. López-Andrés N, Fortuño MA, Díez J, Zannad F, Lacolley P, Rossignol P. Vascular effects of cardiotrophin-1: a role in hypertension? J. Hypertens. 28(6), 1261-1272 (2012).
9. López-Andrés N, Rousseau A, Akhtar R et al. Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction. Hypertension 60(2), 563-573 (2012).
10. Laurent S, Cockcroft J, Van BL et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart. J. 27(21), 2588-2605 (2006).
11. Scuteri A, Najjar SS, Muller DC et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J. Am. Coll. Cardiol. 43(8), 1388-1395 (2004).
12. Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH. Aortic stiffness: current understanding and future directions. J. Am. Coll. Cardiol. 57(14), 1511-1522 (2011).
13. Mancia G, De Backer G, Dominiczak A et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension. J. Hypertens. 25(9), 1751-1762 (2007).
14. Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ. J. 74(1), 24-33 (2010).
15. López-Andrés N, Calvier L, Labat C et al. Absence of cardiotrophin 1 is associated with decreased age-dependent arterial stiffness and increased longevity in mice. Hypertension 61(1), 120-129 (2013).
16. Ou HY, Yang YC, Wu HT, Wu JS, Lu FH. Chang CJ. Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin. Endocrinol. 75(4), 450-455 (2011).
17. Yamashina A, Tomiyama H, Arai T et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens. Res. 26(8), 615-622 (2003).
18. Sugawara J, Hayashi K, Yokoi T et al. Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J. Hum. Hypertens. 19(5), 401-406 (2005).
19. Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, Ioakeimidis N, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension 60(2), 556-562 (2012).
20. McEniery CM, Yasmin, Hall IR et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J. Am. Coll. Cardiol. 46(9), 1753-1760 (2005).
21. Benetos A, Adamopoulos C, Bureau JM et al. Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 105(10), 1202-1207 (2002).
22. Tomiyama H, Yamashina A, Arai T et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects. Atherosclerosis 166(2), 303-309 (2003).
23. Kool MJ, Hoeks AP, Struijker Boudier HA, Reneman RS, Van Bortel LM. Short- and long-term effects of smoking on arterial wall properties in habitual smokers. J. Am. Coll. Cardiol. 22(7), 1881-1886 (1993).
24. Tomiyama H, Hashimoto H, Tanaka H et al. Continuous smoking and progression of arterial stiffening. J. Am. Coll. Cardiol. 55(18), 1979-1987 (2010).
25. van de Laar RJ, Ferreira I, van Mechelen W, Prins MH, Twisk JW, Stehouwer CD. Habitual physical activity and peripheral arterial compliance in young adults: the Amsterdam growth and health longitudinal study. Am. J. Hypertens. 24(2), 200-208 (2011).
26. Ferrier KE, Waddell TK, Gatzka CD, Cameron JD, Dart AM, Kingwell BA. Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension. Hypertension. 38(2), 222-226 (2001).
27. Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton- Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension 42(4), 468-473 (2003).
28. Seo HS, Kang TS, Park S et al. Insulin resistance is associated with arterial stiffness in nondiabetic hypertensives independent of metabolic status. Hypertens. Res. 28(12), 945-951 (2005).
29. Li CH, Wu JS, Yang YC, Shih CC, Lu FH, Chang CJ. Increased arterial stiffness in subjects with impaired glucose tolerance and newly diagnosed diabetes but not isolated impaired fasting glucose. J. Clin. Endocrinol. Metab. 97(4), E658-E662 (2012).
30. Stacey RB, Bertoni AG, Eng J, Bluemke DA, Hundley WG, Herrington D. Modification of the effect of glycemic status on aortic distensibility by age in the multi-ethnic study of atherosclerosis. Hypertension 55(1), 26-32 (2010).
31. Van Bortel LM, Duprez D, Starmans-Kool MJ et al. Clinical applications of aterial stiffness, Task Force III: recommendation for user procedures. Am. J. Hypertens. 15(5), 445-452 (2002).
32. Yamashina A, Tomiyama H, Takeda K et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens. Res. 25(3), 359-364 (2002).
33. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 54(6), 1328-1336 (2009).